Company News
Fujifilm Showcases Its Latest Medical Devices At The 73rd Annual IRIA Conference 2020
- Showcases the extensive broad portfolio of Advanced Medical Imaging and Information System
- Announces the launch of two books on emerging technology in diagnosis and management of breast cancer
New Delhi, 23 January 2020: Fujifilm India Private Limited, one of the leaders in Healthcare industry, today, displayed its latest medical systems at the 73rd National Conference of the Indian Radiological and Imaging Association (IRIA). The three-day long conference is scheduled from 23rd – 26th January 2020 at MMCC, Gandhinagar, Ahmedabad, India. As part of the event, Fujifilm will be displaying its latest medical devices like FDR – Smart F, FDR – D-EVO II, FDR – SE Lite, FCR – Prima T, Full Field Digital Mammography (FFDM) – Amulet Innovality and Synapse PACS.
In DR systems, the company is displaying the FDR Smart F – Fujifilm’s latest high quality, cost effective digital X-ray system that can be easily installed in limited spaces and is easy to use. This product was especially designed for emerging countries like India. Whereas in the FDR D-EVO series, the company will be showcasing FDR – D-EVO II detector that allows smart image processing and dose efficiency for the patients. Fujifilm will also preview the FDR SE Lite retrofit DR detector at the annual meeting. The detector is geared towards bringing DR technology to specialty and small medical practices. In CR systems, Fujifilm will be displaying the Prima TM – an affordable High-speed image processing tabletop FCR (Fuji Computed Radiography) with mammography compatibility. The machine supports a space saving design and provides superior image quality of 50 Micron resolutions.
In Medical Informatics, the company will showcase the SYNAPSE-PACS, RIS and Mobility Solution to provide improved workflow, efficiency and quality of reporting in radiology departments. Since 1999, Synapse® has been transforming healthcare organizations with continuous innovation in diagnostic image management, advanced visualization, enterprise imaging workflow and shared informatics architecture.
In the Ultrasound space, Fujifilm will display the SonoSite X-Porte FC-I – an ultrasound machine with breakthrough extreme definition imaging for pinpoint precision. It comes with educational resources such as step-by-step tutorials viewable simultaneously with live scans. Also on display will be the newly launched Visionary DX – BMD, Newtom – CBCT and X-Air (Hand-held Portable X-ray system).
Commenting on the association with IRIA 2020, Mr. Haruto Iwata, Managing Director, Fujifilm India Pvt. Ltd. said, “Today’s healthcare enterprises are entirely focused on improving the quality of healthcare and we at Fujifilm are principally committed at bringing advanced imaging strategies keeping in mind the industry needs. With increasing digitalization and use of AI in healthcare, we aim to provide our users high value care with the cutting edge technologies. As trailblazers in healthcare sector, we are proud to showcase our wide range of medical systems at the 73rd National Conference of the Indian Radiological and Imaging Association. We have designed these technologies to offer comfortable, efficient procedures and help clinicians deliver the best possible patient outcomes.”
“At Fujifilm, our key focus areas are Early Detection of Breast Cancer, End T.B Program, Early Detection of lung cancer and colon cancer through state-of-the-art products likes Full Field Digital Mammography, FCR & FDR Systems, Endoscopy Systems. We are even focused on digitization Tele radiology and AI for faster and quality diagnosis of Breast Cancer, Tuberculosis and Lung Cancer. With such associations, we will continue to innovate and provide high quality medical solutions that contribute to better healthcare facilities and services in India.” added Mr. Chandrasekhar Sibal, Senior Vice President – Medical Division, Fujifilm India Pvt. Ltd
The company will also announce the launch of two books at the conference i.e. Full Field Digital Mammography – CEDM written by Dr Rashmi Sudhir from Indo American Cancer Hospital, Hyderabad and FDR – “Digital Radiography the Power of Imaging” (A book on case done by our users on our DR systems). The books highlight the emerging technology in diagnosis and management of breast cancer. It further highlights unique technologies by Fujifilm that offer solutions to support these diagnosis at an early stage.
About Fujifilm India Private Ltd
Fujifilm established in 1934 has believed in Innovation and creation of new values through leading edge and proprietary technologies. FUJIFILM India as a firm believer in innovation continues to work hard to provide the Indian consumer the best products and services.
Our corporate slogan is “Value from Innovation.”
Along with expressing Fujifilm’s commitment to continuously creating innovative technologies, products and services that empower the potential and expand the horizons of tomorrow’s businesses and lifestyles, the slogan also encapsulates the company’s desire to combine our own original technology with human resources, expertise and technology from around the world both internally and externally to create innovation. A new brand statement has also been created to articulate these commitments more specifically, and the slogan encapsulates the main points of the brand statement.
Our Goal is to be a company that is able to resolve a diverse variety of the problems that face society, contribute to the world through the continuous creation of value – added products and services, and achieve sustainable growth through constant innovation. That was the commitment we made to the world when we launched our new corporate slogan “Value from Innovation”. We quickly ascertain customer needs, and communicate these clearly and accurately to those involved in product development. Instant camera – instax is successful example of this in Photo Imaging business which was developed after accurately assessing market demands and with all related business divisions working together throughout the entire process from production to sales on a worldwide scale.-MB Bureau
